We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$64.6B
AUM Growth
+$1.37B
Cap. Flow
-$686M
Cap. Flow %
-1.06%
Top 10 Hldgs %
38.17%
Holding
995
New
43
Increased
362
Reduced
491
Closed
59

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$36.3M
2
SCHW
Charles Schwab
SCHW
+$36.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$35.6M
4
DHR icon
Danaher
DHR
+$30.5M
5
QURE icon
uniQure
QURE
+$28.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$93.5M
2
MELI icon
Mercado Libre
MELI
+$86M
3
MSFT icon
Microsoft
MSFT
+$62.9M
4
AAPL icon
Apple
AAPL
+$55.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 32.59%
2 Healthcare 13.39%
3 Consumer Discretionary 11.41%
4 Communication Services 11.25%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$339B
$319M 0.49%
1,634,355
+40,395
+3% +$9.62M
COST icon
27
Costco
COST
$432B
$307M 0.48%
356,098
-5,975
-2% -$5.41M
NFLX icon
28
Netflix
NFLX
$307B
$304M 0.47%
3,243,837
-70,613
-2% -$7.61M
CRM icon
29
Salesforce
CRM
$154B
$299M 0.46%
1,127,840
-27,701
-2% -$6.88M
DHR icon
30
Danaher
DHR
$138B
$296M 0.46%
1,292,583
+138,852
+12% +$30.5M
CAT icon
31
Caterpillar
CAT
$361B
$283M 0.44%
494,496
-5,724
-1% -$3.18M
UNH icon
32
UnitedHealth
UNH
$382B
$279M 0.43%
843,742
-87,866
-9% -$29.8M
HD icon
33
Home Depot
HD
$337B
$276M 0.43%
803,398
-6,951
-0.9% -$2.55M
BSX icon
34
Boston Scientific
BSX
$68.4B
$252M 0.39%
2,644,312
-632
-0% -$62K
AXP icon
35
American Express
AXP
$224B
$252M 0.39%
681,172
-26,210
-4% -$9.38M
NU icon
36
Nu Holdings
NU
$67.8B
$251M 0.39%
15,004,383
+2,260,642
+18% +$36.3M
SPOT icon
37
Spotify
SPOT
$108B
$250M 0.39%
430,841
-882
-0.2% -$551K
ABT icon
38
Abbott
ABT
$188B
$250M 0.39%
1,993,536
+23,817
+1% +$3.03M
MDT icon
39
Medtronic
MDT
$112B
$247M 0.38%
2,576,475
+28,932
+1% +$2.81M
ACN icon
40
Accenture
ACN
$106B
$247M 0.38%
919,522
+3,415
+0.4% +$868K
PLD icon
41
Prologis
PLD
$136B
$245M 0.38%
1,920,118
+63,995
+3% +$7.98M
TJX icon
42
TJX Companies
TJX
$179B
$245M 0.38%
1,592,515
-138,470
-8% -$20.5M
GS icon
43
Goldman Sachs
GS
$289B
$243M 0.38%
276,385
-6,062
-2% -$4.95M
WFC icon
44
Wells Fargo
WFC
$254B
$243M 0.38%
2,603,139
-55,619
-2% -$4.83M
MU icon
45
Micron Technology
MU
$835B
$235M 0.36%
823,437
-4,425
-0.5% -$1.02M
TMO icon
46
Thermo Fisher Scientific
TMO
$214B
$222M 0.34%
383,832
+5,895
+2% +$3.33M
ADI icon
47
Analog Devices
ADI
$172B
$222M 0.34%
818,651
-26,908
-3% -$6.76M
NOW icon
48
ServiceNow
NOW
$120B
$222M 0.34%
1,448,931
+14,301
+1% +$2.45M
PLTR icon
49
Palantir
PLTR
$295B
$219M 0.34%
1,232,737
-37,045
-3% -$6.71M
ISRG icon
50
Intuitive Surgical
ISRG
$127B
$216M 0.33%
380,508
-7,568
-2% -$4.03M

Similar funds

Aberdeen Group's Q4 2025 Portfolio in Review

As of Q4 2025, Aberdeen Group held 995 positions worth $64.6B, up 2.2% from $63.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aberdeen Group's Q4 2025 filing shows 43 new, 362 increased, 491 reduced and 59 closed positions. Its largest new stake was Praxis Precision Medicines: 134,992 shares worth $39.8M. The largest sale was Eli Lilly, an estimated $93.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q4 2025 buy was Praxis Precision Medicines: 134,992 shares worth $39.8M.
  • Aberdeen Group added most to Nu Holdings in Q4 2025, an estimated $36.3M increase.
  • Aberdeen Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $93.5M.
  • Aberdeen Group fully exited BioMarin Pharmaceuticals in Q4 2025, selling an estimated $48.9M.
  • Aberdeen Group's ten largest holdings make up 38% of its $64.6B portfolio in Q4 2025.
  • Aberdeen Group opened 43 new positions and closed 59 in Q4 2025.
  • Aberdeen Group's portfolio value rose 2.2% quarter-over-quarter to $64.6B.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.